SUMMARY By analysing leucocyte subpopulations with monoclonal antisera, we have shown that the diagnosis of severe combined immunodeficiency can be made soon after birth. The technique of staining has been adapted for small blood samples, and normal ranges of leucocyte subpopulations have been established for fetal blood taken from midtrimester pregnancies. Using this information, we gave prenatal advice to an at risk family and predicted that the pregnancy would be normal; this was confirmed after birth. This technique should allow prenatal diagnosis for severe combined immunodeficiency, especially if the phenotype of a previously affected child is known.
Severe combined immunodeficiency (SCID) is a heterogeneous syndrome inherited either as an X-linked or an autosomal recessive disorder. Affected children lack both cell-mediated and humoral immunity; they present with repeated 
Methods
Staining mononuclear cells. Venous blood specimens were obtained from 2 children with SCID in the first 2 days of life, and from 5 others below the age of 6 months. Mononuclear cells were obtained by Ficoll-Triosil centrifugation and after washing were stained with monoclonal mouse antisera (aliquots of cells at 2 x 105/ml) to human leucocyte subpopulations. The following antisera were used: (1) UCHT1 which recognises all mature T-cells.4 (2) Leu 3a which recognises helper/inducer T-cells.5 (3) Leu 2a which recognises suppressor/cytotoxic T-cells.5 (4) DA2 which recognises a non-polymorphic determinant of HLA Dr antigen.6 (5) 
Results
The phenotype of the lymphocyte populations of the 7 children with SCID is shown in Table 1 and compared with the normal ranges for children of this age established in our laboratory. The pattern of Tand B-cell antigen expression is heterogeneous, but is constant if tested repeatedly for each child. Furthermore, within families, if one child has SCID with high B-cell numbers, further affected children show the same pattern (personal experience).
In Table 2 the results of leucocyte subpopulations found in normal fetal blood (range of 11 samples 
Addendum
Since this report was accepted we have screened a second at risk fetus at 19 weeks' gestation. The male fetus was shown to have SCID with high B-cell numbers (same pattern as affected first child) and was aborted. The diagnosis was confirmed by the absence of lymphocyte response to phytohaemagglutinin and at necropsy of the fetus by an absence of the T-cell areas in the thymus and spleen.
